All cards Flashcards
<p><span>What are 3 features unique to gram-negative bacteria?</span></p>
<ol>
<li><span>thin peptidoglycan (PG)</span></li>
<li><span>Safranin (red)</span></li>
<li><span>outer lipid rich membrane + lipoproteinsrepel many drug: polar drugs enter through porins to access PG</span></li>
</ol>
<p><span>Which is easier for a drug to penetrate- gram positive or negative bacteria, and why?</span></p>
<p><span>Gram positive, low MW enter easily across exposed PG layer, itself a key target</span></p>
<p><span>How does the murein (peptidoglycan) layer differ between gram positive and negative bacteria?</span></p>
<p><span>Gram positive: thick PG</span></p>
<p><span>Gram negative: thin PG</span></p>
<p><span>How does gram staining distinguish between gram positive and negative bacteria?</span></p>
<p><span>Gram<u> p</u>ositive:<u>p</u>urple dye</span></p>
<p><span>Gram negative: safranin (red)</span></p>
<p><span>Ribosomes and cell walls are common targets for antibiotics – which is unique to bacteria, and which is slightly different from its human counterpart?</span></p>
<p><span>bacteria vs humans:</span></p>
<ul>
<li><span>cell wall (humans have no cell walls) </span></li>
<li><span>70Sribosome (humans: 80S)</span></li>
<li><span>outer membrane (gram negative only)</span></li>
<li><span>Different needs for substrates</span></li>
</ul>
<p></p>
<p><span>What are the differences between bactericidal and bacteriostatic antibiotics, and which one requires a competent immune system to resolve the infection?</span></p>
<p><span>Bactericidal: kills bacteria; irreversible (penicillin)</span></p>
<p><span>Bacteriostatic: prevent replication; reversible (tetracycline) - the patient’s own immune system must deal with getting rid of rest of the infection</span></p>
<p><span>Describe 3</span><span><u>(there are 4 in the lecture)</u></span><span><u></u></span><span>categories of adverse effects of antibiotics – which is specific to antibiotics?</span></p>
<ol><li><span><u>Direct toxicity</u>: aminoglycosides generate free radicals that damage neurons in inner ear</span></li><li><span><u>Allergic reactions</u>: rapid, immune-mediated development of rash, hives</span></li><li><span><u>Idiosyncratic reactions</u>: hemolysis in G-6-PD-deficient patients treated with sulfonamides</span></li><li><span><u>Changes in normal body flora</u>: killing some bacteria allows other to proliferate; vaginal yeast infections<strong>(this is specific to antibiotics)</strong></span></li></ol>
<p><span>Contrast between prophylactic, pre-emptive, empiric and definitive / directed therapy.</span></p>
<p><span><u>Prophylactic</u>: antibiotic used before an infection</span></p>
<p><span><u>Pre-emptive therapy</u>: antibiotic used during symptoms occur to prevent anticipated infection or symptoms</span></p>
<p><span><u>Empiric therapy</u>: selection of an antibiotic based on<strong>most likely</strong> cause of infection</span></p>
<p><span><u>Definitive/directed therapy</u>: selection of an antibiotic based on<strong> positive identification</strong> of the causative organisms</span></p>
<p><span>Define the terms “sensitivity”, “MIC”, and “clinical breakpoint”</span></p>
<p><span><u>Sensitivity</u>: the ability of a bacteria to be inhibited/killed by a particular antibiotic; drug affects the bacteria at<strong>lowest concentration</strong> is the one to which it’s<strong>most sensitive</strong></span></p>
<p><span><u>Minimum inhibitory concentration (MIC)</u>: lowest concentration of drug that<strong>inhibits</strong>growth of organism</span></p>
<p><span><u>Clinical breakpoint</u>: highest plasma concentration that can safely be achieved in a patient</span></p>
<p><span>What is the purpose of broth dilution and disk diffusion testing?</span></p>
<p><span><u>Broth dilution</u>: bacteria in<strong> liquid</strong> are exposed to<strong>increasing concentrations</strong> of a drug - the lowest concentration that eliminates growth is MIC</span></p>
<p><span><u>Disk diffusion</u>: bacteria are plated onto<strong>agar studded</strong> with small disks containing<strong>different antibiotics</strong> - if bacteria surrounding a disk are dead, they are susceptible to that drug</span></p>
<p><span>How are MIC and breakpoint concentrations used together to determine bacterial sensitivity?</span></p>
<p><span><u>Sensitive</u>: MIC < breakpoint</span></p>
<p><span><u>Intermediate</u>: MIC near breakpoint</span></p>
<p><span><u>Resistant</u>: MIC > breakpoint</span></p>
<p><span>Contrast between the terms “broad spectrum” and “narrow spectrum” – why would a narrow spectrum drug sometimes be more appropriate?</span></p>
<p><span><u>Broad spectrum</u>: active against many types of bacteria</span></p>
<p><span><u>Narrow spectrum</u>: active against only one or a few types of bacteria (might be more appropriate: to<strong>kill/inhibit only unwanted</strong> bacteria; lessen resistance)</span></p>
<p><span>Contrast between time- and concentration-dependent antibiotic effects, and the dosing strategy required for each – give an example drug for each.</span></p>
<p><span><u>Time dependent</u>: constant rate of killing, provided that drug concentration exceeds MIC (beta lactams)</span></p>
<p><span><u>Concentration-dependent</u>: rate of killing increase with drug concentration above MIC (aminoglycosides)</span></p>
<p><span>State 3 advantages of combining antibiotic drugs - are all combinations of antibiotics equally beneficial, or can some be detrimental?</span></p>
<ol><li><span><strong>both MOA</strong> to produce a<strong>synergistic</strong> effect (greater than sum of individual drugs), in some cases combined antibiotics can<strong>antagonize</strong> each other’s effects</span></li><li><span>Combining antibiotics can also<strong>minimize risk of resistance</strong> development</span></li><li><span><strong>Lower doses</strong> of each agent can be used,<strong>minimizing side effect severity</strong></span></li></ol>
<p><span>What is the difference between intrinsic and acquired resistance?</span></p>
<p><span><u>Intrinsic:</u> trait that confers protection against antibiotic action, shared by all members of a bacterial species, not related to antibiotic exposure</span></p>
<p><span><u>Acquired</u>: certain gene changed become favored as a result of pressure from antibiotic exposure</span></p>
<p><span>What are 4 general mechanisms by which bacteria can become resistant to antibiotics, and which one of these is specific to gram negative bacteria?</span></p>
<ol><li><span><u>Altered receptors or targets</u> so drugs cannot bind (vancomycin)</span></li><li><span><u>Drug destruction</u> or inactivation (beta lactams)</span></li><li><span><u>New resistant pathway</u> (sulfonamides)</span></li><li><span><u>Decreased drug exposure</u>: less uptake/more efflux (regulating outer membrane pore function, or efflux transporter expression) - this mechanism is relevant to</span><span> gram negative</span><span> bacteria</span></li></ol>
<p><span>Can more than one resistance mechanism appear in the same strain of bacteria?</span></p>
<p><span>With in same species of bacteria, there may be multiple strains with varying types of resistance</span></p>
<p><span>A single species may have multiple acquired resistance mechanisms</span></p>
<p><span>What are the 3 main modes of horizontal transfer of acquired resistance, and how does each work?</span></p>
<ol><li><span><u>Transformation</u>: uptake of naked DNA containing resistance genes</span></li><li><span><u>Transduction</u>: DNA transferred by infection with viruses</span></li><li><span><u>Conjugation</u>: DNA transfer between bacterial cells via plasmid exchange</span></li></ol>
<p><span>Are resistance genes always acquired horizontally (from another organism)?</span></p>
<p><span>Bacterial<strong>proliferation</strong> and<strong>transfer</strong> between hosts (poor hygiene, hospital acquired infections)</span></p>
<p><span>Increased<strong>exposure</strong> of bacteria to<strong>antibiotics</strong> -> selection pressure (over prescription, wrong prescription, use in agriculture)</span></p>
<p><span>What is “antibiotic stewardship”?</span></p>
<p><span>coordinated data-driven programs that focus on reducing inappropriate antibiotic use in clinical settings and agriculture</span></p>
<p><span>What are two general categories of initiatives that are being supported to combat drug resistance development?</span></p>
<ol><li><span>Government</span></li><li><span>WHO, World Bank</span></li></ol>
<p>What are the 4 major classes of beta lactam antibiotics, and how can one recognize names of drugs in each class?</p>
<p>Penicillins: (-cillin)<br></br>Cephalosporins: (-cef-)<br></br>Carbapenems: (-penem)<br></br>Monobactams (aztreonam)</p>
What are the 4 major classes of penicillins?
<ul><li>Natural Penicillins:<ul><li>Penicillin G</li><li>Penicillin V</li></ul></li><li>Anti-staphylococcal:<ul><li>Nafcillin and Oxacillin</li><li>Dicloxacillin</li></ul></li><li>Amino/ Broad spectrum:<ul><li>Ampicillin</li><li>Amoxicillin</li></ul></li><li>Extended Spectrum:<ul><li>Piperacillin + tazobactam</li></ul></li></ul>
<p><span>Name 4 examples of beta lactamase inhibitor drugs.</span></p>
<ul><li><span>Clavulinic Acid</span></li><li><span>Sulbactam</span></li><li><span>Tazobactam</span></li><li><span>Avibactam</span></li></ul>
What feature is shared in the names of all glycopeptide antibiotics?
-van-
Name the classes (and the 2 additional “other” drugs) that target bacterial cell membranes.
- Other cell wall antibiotics: fosfomycin, bacitracin
- Lipopeptides: dapotomycin
- Polymyxins (-myxin)
Name 2 drugs that primarily target bacterial cell membranes.
Daptomycin: disrupts cytoplasmic membrane
Polymyxins: disrupt the outer membrane + cytoplasmic membrane
What are the two major components of peptidoglycan?
Polysaccharides: 2 alternating sugars - N-acetylglucosamine (G) and N-acetylmuramic acid (M)
Peptides: five amino acid chain, linked N-acetylmuramic acid sugar
What are the 3 major steps in PG synthesis – what happens in each step?
Monomer synthesis & transport: in cytoplasm, building blocks are made from amino acids & sugar by enzyme (Mur enzyme), then transported to the cell surface by lipid carriers.
Glycan polymerization: at cell surface, N and M sugars are connected into strands via transglycosylation by penicillin binding proteins (PBPs)
Polymer cross-linking: strands are linked by transpeptidation, when penicillin binding proteins (PBPs) remove the peptide’s terminal D-alanine to cross-link it to another peptide
What are the roles of PBP (both roles), Mur enzymes, and flippase II enzymes?
PBP often have both transpeptidase domain and glycosyltransferase domain
Mur A enzyme: building blocks made from amino acids and sugar
Flippase II enzymes: transport building blocks to cell surface
Which steps in the PG synthesis pathway are targeted by: β lactams, glycopeptides, fosfomycin and bacitracin - and to what target does each one bind?
Photo attached below
What are 2 drugs that target the cell membrane, and how does each work?
Daptomycin: disrupts cytoplasmic membrane
Polymyxins: disrupt the outer membrane + cytoplasmic membrane
What are the 4 primary mechanisms by which bacteria become resistant to β lactam drugs?
- Inactivation of antibiotic by bacterial beta-lactamase: these enzyme catalyzed opening of the antibiotic’s beta-lactam ring
- Reduced uptake of antibiotic: specific to gram-negative bacteria (impervious outer membrane)
- Antibiotic efflux: gram negative bacteria may produce drug efflux pumps which toss some beta-lactam antibiotics back out
- Alteration of the antibiotic’s target: bacteria produce slightly different PBPs that antibiotics can’t bind to: development of a new PBP (PBP2a) by S. aureus is how the “superbug” MRSA arose
Which of the 4 mechanisms of how bacterial resistance develops against cell wall / membrane-targeted agents is the most common?
Inactivation of antibiotic by bacterial beta-lactamase
What is the function of bacterial beta lactamase enzymes?
they protect beta-lactam antibiotics from ring-destruction (counter-defense)
What type of bacteria are more likely to develop antibiotic resistance by altering drug uptake / efflux – gram positive or negative (and why)?
Gram negative. They have an impermeable outer membrane.
Example: development of a new PBP (PBP2a) by S. aureus is how the “superbug” MRSA arose
Give 3 examples of how bacteria can develop antibiotic resistance by altering antibiotic binding targets.
- these enzymes catalyze opening of the antibiotic’s beta-lactam ring
- most but not all bacteria produce beta-lactamase enzyme to defend themselves from antibiotics
- bacteria make hundreds of different beta-lactamase enzymes, each degrades a particular range of beta-lactam antibiotics
What is the mechanism by which MRSA developed resistance to penicillins?
Alteration of the antibiotic’s target: bacteria produce slightly different PBPs that antibiotics can’t bind to
-all available beta lactam antibiotics (except two new cephalosporins) fail to bind to MRSA’s new PBP (PBP2a)
-MRSA is currently treatable with vancomycin, daptomycin and ceftaroline
Which class of beta lactam antibiotics has the broadest spectrum of activity?
Carbapenems (-penem): Imipenem, Meropenem
Which 1 class of beta lactams antibiotics has activity against gram negative bacteria only?
Monobactams: Aztreonam (gram negative only)
Among the 4 categories of penicillins, which 2 have a narrow spectrum of activity, and which 1 has the broadest spectrum of activity?
- Narrow spectrum:
- Natural Penicillins: Penicillin G (IV), Penicillin V (PO)
- Anti-Staphylococcal: Naficillin and Oxacillin (IV), Dicloxcillin (PO)
- Broadest spectrum:
- Extended Spectrum: Piperacillin + tazobactam (IV/IM)
All penicillins have activity against which type of bacteria – gram positive or gram negative?
Gram Positive!
Name 6 antibiotic classes / subclasses / drugs that can be used to treat MDR strains of bacteria
- Cephalosporins (5th generation, IV): Ceftaroline, ceftolozane + tazobactam
- Carbapenems: Imipenem (combine with beta-lactam inhibitor to provide activity against MDR bacteria)
- Glycopeptide: Vancomycin (more use recently due to rise in MDR bacteria)
- Other cell wall agents: Fosfomycin
- Cell membrane agents: Polymyxins
- Daptomycin (Lipopeptide - cell membrane agent)
Which of the β lactams is least likely to have cross-reactivity in patients with penicillin allergy?
Monobactams: Aztreonam (NO CROSS REACTIVITY)
Which β lactam drug class is associated with the highest risk of C difficile colitis?
Cephalosporins (3rd generation): cefituten (PO), cefotaxime, ceftriaxone (-one, -ten, -ime)
Which antibiotic drug produces a classic constellation of side effects including histamine-mediated flushing, ototoxicity and nephrotoxicity?
Glycopeptides: Vancomycin
Which β lactam subclass can cause alcohol intolerance, hemolysis, impaired coagulation and C diff. colonic overgrowth?
Cephalosporins (3rd generation): cefituten (PO), cefotaxime, ceftriaxone (-one, -ten, -ime)
Which β lactam drug is mainly cleared by renal metabolism?
Carbapenems (-penem): Imipenem, Merapenem, Doripenem, Ertapenem
Which one of the 4 classes of beta lactam antibiotics is only available IV (and why)?
Carbapenems (-penem): Imipenem, Merapenem, Doripenem, Ertapenem
Because they have very short half lives
Give examples of 2 antibiotics that are more likely to cause concentration-dependent risk of seizures?
- Natural Penicillins: Penicillin G (IV or IM)
- Carbapenems (-penem): concentration-dependent seizure risk (Imipenem, Merapenem, Doripenem, Ertapenem) [Imipenem highest risk]
How can one recognize the names of beta lactamase inhibitor drugs, and what is the one exception to this rule?
- Beta Lactamase inhibitor (usually-bactam):
- Sulbactam, Tazobactam, Avibactam
Exception: Clavulanic Acid
What is the purpose of beta lactamase inhibitor drugs?
Combined with beta lactam antibiotics to overcome bacterial drug resistance
Are beta lactamase inhibitors generally administered with non-beta lactam antibiotics?
No, it is usually administered with beta lactam antibiotics
Which antibiotic must be administered in combination with cilastatin, and what is the purpose of cilastatin in this combination?
Carbapenems: Imipenem (must combine with cilastatin (DHP-1 inhibitor) to achieve therapeutic concentration because DHP-1 metabolizes carbezenems
Sulfonamides, (sulfa)
What additional drug is also considered a folate antagonist?
Trimethoprim
What is the major class of DNA synthesis inhibiting antibiotics, and how do you recognize their names?
Fluoroquinolones (flox)
What is one agent that is considered a urinary antiseptic?
Nitrofurantoin
What are the functions of dihydropteroate synthase (DHPS) and dihydrofolate reductase (DHFR) enzymes (which one metabolizes PABA and which one metabolizes dihydrofolic acid)?
DHPS is the enzyme that converts a precursor, PABA, to dihydrofolic acid. DHFR metabolizes dihydrofolic acid to tetrahydrofolic acid (folates!).
Is folate synthesis from PABA a bacteria specific process? Which portion of the pathway is shared by both bacteria and humans?
Yes, the portion where dihydrofolic acid is converted into folates is shared by both bacteria and humans.
Which enzyme is inhibited by sulfonamides, and which by trimethoprim?
Sulfonamides-DHPS
Trimethoprim-bacterial DHFR blocking folate synthesis
What is the function of the topoisomerase enzymes (DNA gyrase and Top IV)?
The unwinding process is done by topoisomerase, DNA gyrase (alters DNA supercoiling), topoisomerase IV (separates interlocked strands)
Do humans have topoisomerases? If so, how do antibiotics target topoisomerases without affecting human cells?
Yes, humans do have topoisomerase. Fluoroquinolones are specific inhibitors of bacterial topoisomerases.
How does nitrofurantoin selectively target bacterial vs. human cells?
Bacterial selectivity is due to more rapid bacterial conversion to reactive intermediates in bacteria vs humans
- Overproduction of PABA
- Structural changes to DHPS enzyme to reduce its affinity to sulfonamides
- Changes in permeability that reduce the ability of sulfonamides to enter the bacterial cell
What 3 mechanisms provide bacteria with resistance to trimethoprim?
- Reduced cell permeability
- Overproduction of DHFR
- Production of an altered reductase that doesn't bind trimethoprim well
Is resistance to nitrofurantoin common or rare?
Rare
Among the drugs/classes covered in this lecture, which has the broadest spectrum of activity?
Fluoroquinolones
Name one class and one combination (class + drug) that have activity against multi-drug resistant bacteria
Fluoroquinolones (one class) Trimethoprim-Sulfamethoxazole (class+drug)
For which class is use limited to serious or treatment-resistant infections, and why?
Fluoroquinolones
What is the one use of nitrofurantoin?
UTI
What class is used topically for burns and as eyedrops for eye infections?
Sulfonamides
Which class tends to have cross-allergenicity with many other drug classes?
Sulfonamides
Which class tends to produce urine crystals, hematologic toxicity and hemolytic reactions in G6PD deficient individuals?
Sulfonamides
Which other drug can also produce hemolytic reactions in G6PD deficient individuals?
Nitrofurantoin
Which class is generally well tolerated, but has many FDA warnings for rare serious side effects? (Name 4 examples of rare serious side effects with this class of drug).
- Fluoroquinolones
- Tendinitis and tendon rupture
- Peripheral neuropathy
- CNS effects
- Aortic aneurysm/dissection
Which class is generally well tolerated, but can produce neuropathy / pulmonary toxicity if the drug can’t be cleared by kidneys?
Nitrofurantoin
What drug is often given with sulfonamides, and what are the 2 advantages of this combination
- Trimethoprim-sulfamethoxazole (TMP-SMX)
- Effective for a wide variety of infections, including pneumonia and most respiration tract infections, otitis media, UTI’s, prostatitis, uncomplicated skin and soft tissue infections (oral)
- Used for severe pneumocystis pneumonia, alternate therapy for some multidrug-resistant infections (IV)
What drug is often given with sulfonamides, and what are the 2 advantages of this combination
- Trimethoprim-sulfamethoxazole (TMP-SMX)
- Effective for a wide variety of infections, including pneumonia and most respiration tract infections, otitis media, UTI’s, prostatitis, uncomplicated skin and soft tissue infections (oral)
- Used for severe pneumocystis pneumonia, alternate therapy for some multidrug-resistant infections (IV)